Hims & Hers Earnings: -14% Shock as GLP-1 Pivot Hits Margins
Are Hims & Hers Earnings just a temporary GLP-1 growing pain or the start of a tougher chapter for this telehealth favorite? Maik Kemper Editor in Chief Conclusion…
Hims & Hers GLP-1 partnership sparks new weight-loss boom
Can the Hims & Hers GLP-1 partnership with Novo Nordisk turn telehealth weight loss into the company’s next major growth engine? Maik Kemper Editor in Chief When healthcare…
Hims & Hers insider transactions Warning as GLP-1 bets grow
Are Hims & Hers insider transactions hinting at caution just as the company doubles down on its high-stakes GLP-1 obesity strategy? Maik Kemper Editor-in-Chief Conclusion In conclusion, the…
Hims & Hers Novo Nordisk deal sparks 44% premarket surge
Can the new Hims & Hers Novo Nordisk deal really turn an 80% stock collapse into a long-term GLP-1 comeback story? How big is the market reaction to…